Search results
Results from the WOW.Com Content Network
This is a list of emerging technologies, which are in-development technical innovations that have significant potential in their applications. The criteria for this list is that the technology must: Exist in some way; purely hypothetical technologies cannot be considered emerging and should be covered in the list of hypothetical technologies ...
Bayer Healthcare: solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion Larotrectinib [1] Bayer Healthcare: solid tumors that have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion Amifampridine [1] Catalyst Pharmaceuticals: Lambert-Eaton myasthenic syndrome: Pembrolizumab [1] Merck Sharp & Dohme: Merkel ...
Emerging technologies are those technical innovations which represent progressive developments within a field for competitive advantage; [2] converging technologies represent previously distinct fields which are in some way moving towards stronger inter-connection and similar goals. However, the opinion on the degree of the impact, status and ...
UnitedHealth Group said on Tuesday it will remove AbbVie’s blockbuster rheumatoid arthritis drug Humira from some of its lists of preferred drugs for reimbursement as of Jan. 1, 2025, and ...
Affective computing technologies also have the potential to enhance public services by creating emotionally intelligent interfaces that adapt their approach to improve user experience, according ...
In 2018, the U.S. Food and Drug Administration authorized the marketing of the first medical device to diagnose a specific type of eye disease, diabetic retinopathy using an artificial intelligence algorithm. [91] Moreover, AI technology may be used to further improve "diagnosis rates" because of the potential to decrease detection time. [92]
Nanomedicine is the medical application of nanotechnology. [1] Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
Antisense drugs are being developed to treat lung cancer, diabetes and diseases such as arthritis and asthma with a major inflammatory component. [67] It shows that the decreased expression of MLLT4 antisense RNA 1 (MLLT4‑AS1) is a potential biomarker and a predictor of a poor prognosis for gastric cancer.